Tarsus Pharmaceuticals TARS
NASDAQ TARS
$76.75 -0.06 (-0.08%)
As of: Sep 29, 2026 · 3:59 PM EDT

Tarsus Pharmaceuticals (TARS) Gross Margin (2021 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) posted Gross Margin of 93.03% for Q2 2026, down 0.89 percentage points from 93.92% a year earlier and down 1.17 percentage points from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Gross Margin (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Margin at Tarsus Pharmaceuticals was 93.28%, down 0.08 percentage points year-over-year; for FY2025, it came in at 93.20%, up 0.21 percentage points from FY2024.

  • Annual Gross Margin shows a four-year change of -3.16 percentage points (FY2021 to FY2025).
  • In prior years, Tarsus Pharmaceuticals' Gross Margin was 92.99% in FY2024 (+2.12 pp), 90.87% in FY2023 (-5.43 pp), 96.30% in FY2022 (-0.06 pp) and 96.36% in FY2021.
  • Quarterly Gross Margin has run from a low of 79.85% in Q3 2023 to a high of 107.10% in Q4 2021 over five years.
  • On a year-over-year basis, Gross Margin increased in five of the last eight quarters, with an average year-over-year change of +1.98 percentage points.
  • The strongest year-over-year quarter for Gross Margin in the past five years was Q3 2024, with a gain of 13.41 percentage points; the weakest was Q4 2022, with a drop of 11.10 percentage points.
  • According to Business Quant data, Gross Margin for the three prior quarters was 94.20% (Q1 2026), 92.80% (Q4 2025) and 93.00% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Tarsus Pharmaceuticals 3.32 Bn 2.27 Bn 161.80 Mn 93.03%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 93.03%
Mar 31, 2026 94.20%
Dec 31, 2025 92.80%
Sep 30, 2025 93.00%
Jun 30, 2025 93.92%
Mar 31, 2025 93.35%
Dec 31, 2024 92.58%
Sep 30, 2024 93.26%
Jun 30, 2024 92.64%
Mar 31, 2024 94.01%
Dec 31, 2023 90.70%
Sep 30, 2023 79.85%
Mar 31, 2023 100.00%
Dec 31, 2022 96.00%
Jun 30, 2022 96.58%
Mar 31, 2022 93.88%
Dec 31, 2021 107.10%
Sep 30, 2021 94.76%
Jun 30, 2021 96.65%
Mar 31, 2021 96.12%
API Access

Tarsus Pharmaceuticals Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=TARS&period=max&api_key=YOUR_API_KEY